AMGEVITA
Google image searchProduct monograph
Active ingredient
adalimumab, 50 MG/ML
DIN: 02459302
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE PREFILLED AUTOINJECTOR (40MG/0.8ML)
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 19-FEB-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB04 — ADALIMUMAB (ATC/DDD)
Reference brand drug: Humira
